SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012870-97-001335
Filing Date
1997-07-28
Accepted
1997-07-28 00:00:00
Documents
3
Period of Report
1997-06-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 37088
2 STATEMENT OF COMPUTATION OF NET LOSS PER SHARE EX-11.1 2125
3 FINANCIAL DATA SCHEDULE EX-27 2217
  Complete submission text file 0001012870-97-001335.txt   43243
Mailing Address 400 OYSTER POINT BLVD STE 435 SOUTH SAN FRANCSICO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 435 SAN FRANCISCO CA 9402594080 4156350200
ANSAN PHARMACEUTICALS INC (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 97646516
SIC: 2836 Biological Products, (No Diagnostic Substances)